OBJECTIVES: Aortic valve replacement (AVR) for severe aortic valve stenosis (AS) is a Class I indication at the time of coronary artery bypass grafting (CABG). Management of less-than-severe AS in patients undergoing CABG is uncertain however, because the thresholds at which untreated AS impacts long-term outcome are unclear.
INTRODUCTION
More than 1.5 million isolated coronary bypass (CABG) operations were performed in the United States between 2002 and 2011 [1] ; and as older patients present for surgical management of coronary artery disease (CAD), a growing number are also incidentally found to have aortic valve stenosis (AS) on preoperative echocardiography [2] [3] [4] [5] . Severe AS is uniformly considered a Class I indication for aortic valve replacement (AVR) in patients undergoing CABG (level of evidence 'C') [6] . In contrast, results and recommendations of studies investigating management of 'less-than-severe' AS at the time of CABG have been conflicting, giving rise to inconsistent practices and variably interpreted surgical guidelines [4] [5] [6] [7] [8] [9] [10] . To date, reports examining this question (i) have studied heterogeneous cohorts, (ii) introduced selection bias by comparing patients with and without AVR at CABG, and (iii) have not clearly defined whether less-than-severe AS, if untreated at the time of CABG, confers a deleterious impact upon long-term prognosis. Clinical equipoise thus persists due to ongoing debate regarding thresholds at which untreated less-than-severe AS may impact late survival following CABG. A contemporary reappraisal of the debate regarding prognostically influential AS thresholds is particularly relevant in light of the availability of transcatheter aortic valve interventions (TAVI/TAVR). If untreated AS does not influence outcomes, clinicians might instead opt to withhold AVR at the time of CABG under the presumption that if stenosis severity progresses, percutaneous strategies may be deployed at a later date [11] . We thus analysed late outcomes of closely matched cohorts undergoing isolated CABG, differing only by the presence/absence of less-than-severe AS. We sought to define thresholds at which long-term survival is impacted by untreated mild and moderate AS initially identified at the time of CABG; testing the null hypothesis that untreated less-than-severe stenosis is prognostically neutral.
MATERIALS AND METHODS

Study design and population
We conducted a cohort study of patients undergoing isolated CABG with preoperative echocardiographic evidence of whether mild or moderate (less-than-severe) AS was present/absent at index surgery. We studied patients >18 years operated on between 1993 and 2006, and matched those with less-than-severe AS to those without AS. Exclusion criteria were prior aortic valve intervention (AVI), active endocarditis, greater than moderate aortic regurgitation and major concomitant procedures-including valve or thoracic aortic surgery-at the time of CABG. The study complies with the Declaration of Helsinki and was approved by the Mayo Clinic Institutional Review Board. Informed consent was obtained for all patients.
Case identification was by cross-referencing the Cardiovascular Surgery patient database and the Division of Cardiovascular Diseases' Echocardiography repository. From 1 January 1993 to 31 December 2006, 9815 consecutive patients underwent isolated CABG at our institution (Fig. 1) . A total of 2418 patients meeting enrolment criteria underwent preoperative echocardiography within 6 months of surgery, and were stratified into categories of AS severity. While previous studies relied on the mean gradient (MnG) in defining AS [4, 5, 7] , following characterization of low-flow, low-gradient significant AS [12] , and given a recent community-based study identifying aortic valve area (AVA) as the major objective AS determinant of outcome [13] , we defined mild/moderate AS using guideline definitions of AVA (1-2 cm 2 ) [6] . Patients with less-than-severe stenosis (AVA 1-2 cm 2 ; n = 428) were frequency matched to those without AS (AVA >2 cm 2 ; n = 1980) at CABG [14] . Matching by age (±5 years), gender, ejection fraction (EF) (±10%), number of diseased coronary vessels, number of bypass grafts, use of left internal mammary artery (LIMA) graft and surgical year (±5 years) yielded 312 patients per group (Fig. 1) . During the same period, 228 additional patients with less-than-severe AS (23 mild, 205 moderate) underwent concomitant AVR + CABG (2% operative mortality) and were thus not included in our study.
Clinical data
Clinical characteristics were obtained from the Cardiovascular Surgery database, with definitions in accordance with the Society of Thoracic Surgeon's national database. Follow-up data were derived from medical records, postal questionnaires, telephone interviews with patients/next-of-kin, electronic Accurint database (www.Accurint.com) and death certificates. The primary endpoint was all-cause long-term mortality. Secondary end-points were cardiac mortality and AVI, including AVR and transcatheter balloon aortic valvuloplasty. AVI was confirmed by reviewing operative records at our institution and from outside centres.
Echocardiographic assessment
Preoperative Doppler echocardiography within 6 months of CABG was available from the Division of Cardiovascular Diseases' Echocardiography database. Assessment of aortic stenosis and regurgitation was by state-of-the-art methods [15] [16] [17] . AVA was calculated by the continuity equation, and indexed to body surface area. AS severity was further assessed using the peak aortic velocity. Per current guidelines, moderate, mild and no AS were defined by AVA 1-1.5, 1.5-2 and >2 cm 2 , respectively [6] . Left ventricular (LV) function was assessed by EF, cardiac output, cardiac index, stroke volume and indexed stroke volume. Two-dimensional echocardiographic measurements were used, supplemented by M-mode measurements.
Statistical analysis
Continuous variables were summarized with means ± standard deviations and compared between groups by Student's t-test, whereas non-normally distributed data were summarized with medians and interquartile ranges and compared by the Wilcoxon rank-sum test. Categorical variables were expressed as counts and percentages and compared using the χ 2 test. Patients with less-than-severe AS were frequency matched to those without AS at CABG. Frequency matching yields groups with equal distributions of matching criteria without one-to-one patient matching [14] .
Follow-up was calculated from CABG to death or last follow-up. Kaplan-Meier methods estimated overall survival, with censoring at last follow-up. The log-rank test was used to compare survival rates in patients with varying degrees of AS at CABG. Univariate and multivariate Cox proportional hazard models were used to predict long-term mortality risk after CABG. Guideline-defined thresholds of AS severity were the independent variable of interest. In a separate analysis, patients with less-than-severe AS were considered in more detailed ranges of AVA; specifically 1-1.25, 1.25-1.5, 1.5-1.75 and 1.75-2.0 cm 2 . To illustrate the relationship between AS as a continuous parameter and hazard of late death, we used penalized smoothing splines [18] , separately employing AVA and peak velocity as explanatory variables.
The predictive ability of models was described using a concordance index. Cox models were internally validated by bootstrap samples. AVI was treated as a time-dependent covariate accounting for potential survival benefits in patients undergoing late AVI. A P-value of 0.05 was considered statistically significant. Analyses were performed using the SAS 9.13 software (SAS Institute, Inc., Cary, NC, USA).
RESULTS
Follow-up
Follow-up was complete (death, follow-up beyond 1 January 2011, or 10-year follow-up) for 95% (593/624) of patients. The mean follow-up duration was 8 ± 4.5 years, and the last year of follow-up was 2012. Of the 5% (31/624) with 'incomplete' followup, 10 patients were followed up for 6 ± 2.2 years, whereas the remaining 21 had less than 2 years of follow-up.
Baseline clinical and echocardiographic characteristics
Baseline characteristics of all 624 patients, stratified by the presence/absence of AS, are summarized in Table 1 . The mean age was 72 ± 9 years, and 55% (344) were male. For all examined variables known to influence late prognosis-including age, gender, symptoms and comorbidities-there was no significant difference between patients with less-than-severe AS and those without AS at index CABG, indicating successful matching.
The median (interquartile range) duration between preoperative echocardiography and CABG was 7 (3-22) days. Table 2 compares echocardiographic parameters of AS between matched groups, alongside LV haemodynamic characteristics. As expected, all parameters of AS severity were significantly different between groups.
On further stratification of patients with less-than-severe stenosis, those with moderate (n = 87) versus mild (n = 225) versus no AS (n = 312) were comparable across all clinical characteristics, and the three groups followed AS classification echocardiographically across all parameters of stenosis severity (Table 3) .
Perioperative outcomes
All patients underwent 'isolated' CABG without concomitant major procedures. There was no significant difference in operative mortality between patients without AS and those with less-than-severe stenosis at CABG (2 vs 4%; P = 0.1). All other perioperative outcomes were comparable between groups (Table 4) .
Aortic valve intervention
Complete data regarding AVI during follow-up was available for 93% (578/624) of patients. Six percent (37/624) had AVI at a mean age of 75 ± 7 years, and 8 ± 3 years after baseline CABG. Thirty-five of the 37 patients underwent AVR, and 2 had balloon aortic valvuloplasty. Overall, 7% (15/225) of patients with mild AS at index CABG underwent interval AVI, versus 21% (18/87) of those with moderate AS (P < 0.001). All AVIs were without operative mortality.
Long-term mortality
At completion of follow-up, there were 358 deaths (57%) with a mean time to death of 6 ± 4 years. There was a trend towards decreased 12-year survival in patients with AS versus those without AS at CABG (36 ± 3.2 vs 38 ± 3.3%; P = 0.08) despite similar baseline characteristics. On further stratification according to AS severity, 12-year survival was lower with moderate versus mild versus no AS at index surgery (23 ± 5.1 vs 42 ± 3.8 vs 38 ± 3.3%; P = 0.01) (Fig. 2) .
In Cox proportional hazards analysis, moderate AS was a univariate predictor of late mortality [hazard ratio (HR) 1.57, 95% confidence interval (CI) 1.18-2.1; P = 0.002], while mild AS had no prognostic impact (HR 1.07, 95% CI 0.85-1.35; P = 0.56). On multivariate analysis, adjusting for older age (HR 1.37 per 5 years, 95% CI 1.27-1.48; P < 0.001), congestive heart failure (HR 1.48, 95% CI Accounting for interval AVI, we constructed further models with AVI as a time-dependent covariate. While the effect of mild AS on late prognosis remained neutral (HR 1.09, 95% CI 0.86-1.38; P = 0.47), when controlling for the confounding effects of AVI, the mortality risk in patients with untreated moderate AS was 2-fold greater than those without AS (HR = 2.01, 95% CI 1.49-2.73; P < 0.001).
Further sub-stratification of AS by valve area showed that an AVA of 1-1.25 cm 2 was associated with the greatest mortality risk (HR 2.45, 95% CI 1.57-3.82; P < 0.001) ( Table 5 ). To further evaluate the relationship between untreated AS and late mortality, we generated spline functions for AS, using AVA as a continuous variable (Fig. 3) . Progressively smaller AVAs-consistent with worsening stenosis severity-correlated with increased hazard of late death. While risk increased sharply with AVA smaller than 1.5 cm 2 , the 95% CI confirmed a threshold of risk below an AVA of 1.25 cm 2 . Spline curves considering AS by peak velocity again demonstrated that increase in velocity was associated with increased late mortality risk.
Importantly, 12-year survival free of 'cardiac' mortality was significantly lower in patients with baseline moderate versus mild versus no AS (54 ± 7.9 vs 76 ± 3.9 vs 81 ± 3.3%; P < 0.001). Conversely, survival free from 'non-cardiac' mortality was comparable between groups (moderate 44 ± 7.0%, mild 55 ± 4.2%, no AS 47 ± 3.6%; P = 0.4).
DISCUSSION
The significance of less-than-severe AS in patients requiring CABG remains disputed, in part due to the absence of long-term outcome data. This has led to a general state of equipoise when clinicians encounter mild or moderate AS in patients requiring CABG. Specifically, the late prognostic impact of varying degrees of AS should be utilized to make decisions regarding management of concomitant AS. Our study shows, for the first time (based on AVA), that untreated moderate AS identified at the time of isolated CABG is an important, independent determinant of late mortality, and that risk of death increases progressively with smaller AVA. We detail that late mortality risk is intermediate (HR 1.8) in patients with an AVA of 1.25-1.5 cm 2 , and greatest (HR 2.5) in those with an AVA of 1-1.25 cm 2 at index CABG. Conversely, mild AS appears prognostically neutral. These results further define AS severity thresholds that should be considered in the future design of clinical trials aimed at determining the survival impact of various management strategies for AS in patients undergoing CABG.
Studies exploring management of less-than-severe AS at CABG to date have generated conflicting results due to (i) heterogeneity of study cohorts and (ii) selection bias associated with the comparison of patients having AVR at index CABG. Variability in the interpretation of these studies has contributed to inconsistent adoption of surgical guidelines [6] . For instance among patients with mild AS undergoing isolated CABG versus combined AVR + CABG, Sareyyupoglu et al. [5] and Tam et al. [7] both reported no difference in long-term survival between groups; deeming AVR at CABG for mild AS unnecessary [5, 7] . In contrast, using Markov decision analysis methods, Smith et al. [10] proposed that AVR could be considered in sub-sets of patients with mild AS, a position also supported by Hochrein et al. [8] . For those with 'moderate' AS, Pereira et al. noted improved 8-year survival rates in patients undergoing combined AVR + CABG versus isolated CABG [4] , whereas others proposed that a conservative approach may be preferable in sub-groups of moderate stenosis [9] . Importantly, while prior reports examined patients with less-than-severe AS undergoing CABG + AVR versus CABG alone-in some instances with marked differences in baseline characteristics-we instead evaluated closely matched groups of patients all undergoing isolated CABG alone, only differing by the presence or absence of less-than-severe AS. We thus define, for the first time, thresholds at which untreated AS impacts late survival many years following CABG, addressing current clinical equipoise relating to the management of these patients. In light of our data, the aforementioned 'discordant' results are readily understood, as we demonstrate that untreated mild AS does not necessarily impart an excess mortality risk following CABG. We further report that untreated moderate AS imposes an increased long-term mortality risk post CABG. Although it is tempting to make the association, these results cannot be utilized to explain the previously documented survival benefit of AVR [4] .
Our findings indicate that untreated moderate AS at CABG is an independent predictor of increased late mortality. Even after adjusting for age, EF, congestive heart failure, creatinine, diabetes, PVD and interval AVI, the mortality risk in those with untreated moderate stenosis remained double that observed in patients without AS. A slightly different angle was taken in a study by Rosenhek et al. Medically managed moderate AS patients (without CABG) had an 80% increased mortality risk in comparison with age-and gender-matched controls [19] . We uniquely explored thresholds of AVA associated with subsequent mortality risk among patients undergoing CABG, demonstrating that untreated moderate AS is a marker of poor long-term prognosis. In our study, all patients had critical CAD, and we carefully matched them by number of diseased coronary vessels, bypass grafts and use of LIMA as a conduit to minimize the confounding effects of CAD, thereby allowing specific characterization of the mortality risk inherent to untreated moderate AS. While it could be argued that more severe degrees of AS may be surrogates for advanced CAD, this is unlikely given that patients with moderate, mild and no AS in the current report were comparable across all important baseline risk factors. Our observation of increased cardiac mortality associated with moderate AS, particularly in the context of unchanged non-cardiac mortality, lends additional support to our assertion that the increased hazard of death is primarily a function of the stenotic aortic valve. Furthermore, by sub-dividing patients with AS into narrower ranges of AVA, we demonstrated that all categories of untreated moderate AS predicted poor late prognosis. Specifically, patients with AVA 1.25-1.5 and 1-1.25 cm 2 had a 1.8-and 2.5-fold increased mortality risk when compared with those without AS. The severitydependent relationship between worsening AS and increased hazard of death (Fig. 3) provides supporting evidence that the null hypothesis-that untreated AS at CABG is prognostically neutral-is not verified.
The adverse prognostic impact of untreated moderate AS is likely attributable to the progressive nature of this disease. With an estimated average decline in AVA of 0.1 cm 2 /year [20] , it is plausible that patients with the most advanced degrees of moderate AS (AVA 1-1.25 cm 2 ) would progress to severe stenosis within 2-3 years of CABG. Considering that severe AS is associated with excess patient mortality [13] , this lends strength to the notion that concomitant valve intervention at CABG might mitigate deleterious long-term sequelae of moderate AS. Importantly, the current investigation focuses on evaluating thresholds of less-than-severe AS that affect late survival if untreated at the time of CABG; thus deliberation regarding the prognostic value of AVI in these patients is beyond the scope of this study.
Inconsistencies in guideline definitions of grading AS have meant that the echocardiographic parameter of choice in evaluating AS severity has been a point of ongoing controversy [21, 22] . Following characterization of low-flow, low-gradient significant AS [12] , and in light of a recent community-based study reporting AVA as the only major objective AS determinant of outcome [13] , we defined stenosis severity by AVA. Ischaemic LV impairment in patients with critical CAD may reduce ventricular output regardless of EF, and thus reliance upon more flow-dependent indices, such as MnG and peak velocity, may underestimate AS severity. Indeed, while spline function analyses demonstrated that worsening AS, defined by AVA or peak velocity, correlated with increase in late mortality risk, the low peak velocity values in the study cohort-likely secondary to LV impairment-appear to limit the utility of peak velocity in grading AS severity at CABG. Ultimately, in the context of critical CAD, we have shown that AVA allows for an accurate and objective assessment of AS severity, neatly correlating with long-term prognosis.
Through its unique design, this is the first report to our knowledge that comprehensively assesses the long-term prognostic impact of untreated less-than-severe AS at the time of isolated CABG, and identifies thresholds of AS severity corresponding to increased mortality risk. While prior studies have compared patients differing in important risk factors such as age, gender, EF and number of bypass grafts [4, 5, 7] , meticulous frequency matching allowed us to evaluate comparable cohorts. Even after analysing mild and moderate AS independently, baseline characteristics remained comparable between groups. The longer duration and completeness of our follow-up contribute further to the legitimacy of our conclusions regarding the survival impact of untreated less-than-severe AS at CABG.
LIMITATIONS
Although rigorous matching criteria and statistical analyses minimized the potential selection bias, it is impossible to completely rule out the possibility that patients with less-than-severe AS undergoing isolated CABG were somehow different from those with comparable degrees of valve disease but were selected for CABG + AVR; and thus, it is theoretically possible that an increased risk profile may have contributed to inferior survival rates observed in patients with moderate stenosis. Of note, the current study was performed at a high-volume tertiary referral centre, and thus generalizability may be limited to single-centre referent cardiac surgical practices. Finally, as our primary analysis compared long-term outcomes in patients with and without AS undergoing isolated CABG, our results cannot address risks and benefits of concomitant AVR at coronary surgery.
CONCLUSION
Untreated moderate AS identified at the time of isolated CABG is an independent determinant of excess late mortality, while mild AS is prognostically neutral. The risk of late death progressively increases with smaller AVA, and is more than double in patients with an AVA of 1-1.25 cm 2 . These data define thresholds of AS severity for clinical trials aimed at determining whether valve intervention might mitigate this risk.
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